Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

1.50
Delayed Data
As of 10:02am ET
 -0.0193 / -1.27%
Today’s Change
1.31
Today|||52-Week Range
5.97
-21.43%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close1.52
Today’s open1.51
Day’s range1.50 - 1.54
Volume34,595
Average volume (3 months)400,188
Market cap$37.5M
Dividend yield--
Data as of 10:02am ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2,155.56%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+2,928.38%
P/E ratio6.5
Price/Sales1.38
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...+0.10+2.96%
TCONTRACON Pharmaceutica...+0.05+2.27%
NVLSNivalis Therapeutics...+0.01+0.43%
AMPEAmpio Pharmaceutical...+0.01+2.02%
Data as of 10:23am ET, 06/26/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$30.0M
Annual profit (last year)$1.9M
Net profit margin6.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
CFO &
Principal Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts